GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (FRA:L97) » Definitions » Research & Development

Yonghe Medical Group Co (FRA:L97) Research & Development : €2.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Yonghe Medical Group Co's Research & Development for the six months ended in Dec. 2024 was €1.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €2.7 Mil.

Yonghe Medical Group Co Research & Development Historical Data

The historical data trend for Yonghe Medical Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co Research & Development Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 1.49 1.97 2.50 3.76 2.79

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.68 2.09 1.59 1.16

Yonghe Medical Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co  (FRA:L97) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Yonghe Medical Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Yonghe Medical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (FRA:L97) » Definitions » Research & Development
Comparable Companies
HKSE:02389 HKSE:01518 HKSE:02189 HKSE:03689 HKSE:02120 HKSE:00722 HKSE:00557 HKSE:01419 HKSE:02138 HKSE:00383 HCA SAU:4013 XTER:FRE SZSE:300015 XTER:FME XKLS:5225 BSP:RDOR3 BOM:543220 NSE:APOLLOHOSP THC
Traded in Other Exchanges
02279:Hong Kong
Address
11th Floor, 20 Ganluyuan Nanli, China Nuclear E&C Building, Chaoyang District, Beijing, CHN, 100020
Website
https://www.yonghegroup.cn
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. It is principally engaged in the provision of hair transplant services which are subject to similar types of services, similar classes of customers, similar regulatory environment, and similar business risk. The company generated the majority of the revenue from hair transplant services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.

Yonghe Medical Group Co Headlines

No Headlines